There is a lack of consensus among studies on the possible risks of stroke from cigarette smoking; because of this a meta-analysis was conducted. All published data on the association were sought and the relative risk for each study obtained whenever possible. The pooled relative risks were calculated by using estimates of the precision of the individual relative risks to weight their contribution to the meta-analysis. Thirty two separate studies were analysed. The overall relative risk of stroke associated with cigarette smoking was 1.5 (95% confidence interval 1*4 to 1.6). Considerable differences were seen in relative risks among the subtypes: cerebral infarction 1*9, cerebral haemorrhage 07, and subarachnoid haemorrhage 2-9. An effect of age on the relative risk was also noted; <55 years 2.9, 55-74 years 1*8, and -75 years 1.1. A dose response between the number ofcigarettes smoked and relative risk was noted, and there was a small increased risk in women compared with men. Ex-smokers under the age of 75 seemed to retain an appreciably increased risk of stroke (1.5); for all ages the relative risk in ex-smokers was 1-2.
Introduction
The relation between cigarette smoking and stroke has never been clear cut. Reviews and major textbooks over the past 10 years have considered smoking to be either an unlikely or a possible but uncertain risk factor."3 Some publications have suggested that it carries a definite risk, but they have tended not to mention the studies that did not support the association. 4 The lack of consensus is not surprising because relative risks of between 0 5 and 3 0 would be expected from existing publications. At these values many studies would give non-significant results or even suggest a reverse association not reflecting the true pattern. This would be especially likely with smaller studies.
If a consensus is to be achieved results of many studies need to be considered together as individual results seem contradictory. For this reason we thought that a meta-analysis (sometimes called an overview) of all available data was worth while. Meta-analyses have been used mainly to improve the power in a series of clinical intervention trials, some of which had reported non-significant trends. ' Wald et al, however, used the method to estimate a small increased risk of lung cancer in passive smokers,6 and the relative risk of [1] [2] [3] in their report has been widely accepted as the best information we have on the issue. We present the results of our meta-analysis on smoking and stroke.
Methods

CRITERIA FOR SELECTING STUDIES
The publications reviewed in this analysis all provided information on the relation between cigarette smoking and the incidence of cerebrovascular disease and were epidemiological studies investigating possible risk factors in people rather than populations. Studies that examined the relation by using grouped population data to assess geographical and time trends were not included because they are less able to allow for confounding variables and cannot be conveniently compared with studies on individual people. The studies analysed here, therefore, were both concurrent and historical cohort studies, case-control studies, and intervention trials. In many the association between cigarettes and stroke was not of primary interest but a byproduct of research examining other issues.
Strokes of all descriptions were examined as reliably distinguishing subtypes may be difficult and restricting the investigation to particular subtypes seemed of little value. Also, from the public health point of view which particular subtype of stroke a person suffers is often of only academic interest. Our study, therefore, covered categories 430-438 of the ninth revision of the International Classification of Diseases, though precise definitions varied between the investigations. These categories covered cerebral infarction, cerebral haemorrhage, and subarachnoid haemorrhage.
All reports that fulfilled these criteria were assessed. Although the studies varied in quality, avoiding possible biased selection was easier to achieve by this policy. Nine studies were excluded from the metaanalysis because they did not present data that could be used to derive and weight a relative risk.7-'4 COLLECTING INFORMATION Three studies on cigarette smoking and stroke published in widely read medical journals over the past two years were taken as the index references.4 516 All reports referenced in these three reports were reviewed to assess their eligibility for inclusion. This procedure of cross checking references was continued until no new studies were identified. Studies published after 1 May 1988 were not included.
Additional references were sought by using a Medline computer search with cigarette smoking, cerebral infarction, cerebral haemorrhage, subarachnoid haemorrhage, and cerebrovascular disorders as key words. A search back to 1965 identified only four further publications that met the criteria for entry. Care was taken to ensure that only one publication from each survey was included in the analysis. When there were several papers based on a single project the most recent was used. The following details were collected from each publication: name of study, design, subtypes of stroke assessed, population characteristics (for example, sex and age range), methods of dealing with confounding variables, and all data on the association between cigarette smoking and stroke. In one large study (British doctors) the authors were approached and supplied data not available in the original publications.'7 18 We thought it impracticable, however, to approach all authors for data not available in their publications. Odds ratio ¶ [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Odds ratio ¶ Quoted in study [1] [2] Odds ratio ¶ Odds ratio ¶ [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Odds ratio ¶ Quoted in study Quoted in study was the relative risk of stroke among cigarette smokers compared with non-smokers. This was the only measure that could be obtained from both cohort and case-control studies and thus enabled the maximum number of publications to be included. A potential problem with the use of relative risk is that it covers the rate ratio, risk ratio, and odds ratio. As stroke is fairly rare, however, the differences between these ratios are minimal. If a publication enabled more than one measure of relative risk to be derived the order of preference was rate ratio, risk ratio, and odds ratio. The estimates of relative risk were all transformed to their natural logarithm before pooling. The distribution of the natural logarithm of the relative risk is closer to normal than that of the untransformed value. After pooling we transformed the natural logarithm of the relative risk to its antilogarithm for presentation.
MEASURES OF RISK CHOSEN FOR META-ANALYSIS
When we pooled the relative risks of different studies we weighted the relative risk from studies according to the precision of the estimate. The method adopted for weighting entailed calculating the inverse of the variance of the natural logarithm of the relative risk. '9 In cohort studies the variance of the natural logarithm of the rate ratio can be approximated to 1/exposed cases + 1/unexposed cases.20 The same approximation is not unreasonable for risk ratios when the denominator is far larger than the number of cases. In case-control studies the variance of the natural logarithm of the odds ratio is 1/exposed cases + 1/unexposed cases + 1/exposed controls + 1/unexposed controls.20 In matched studies an estimate of the variance of the natural logarithm of the odds ratio is calculated from discordant pair data: 1/exposed cases matched with unexposed controls + 1/exposed controls matched with unexposed cases.20 If the above data were We investigated the risks for cigarette smoking in the three main subtypes. The diagnosis of cerebral infarction included both cerebral thrombosis and cerebral embolism as distinguishing the two is often impossible. Within the subtype cerebral haemorrhage were included some studies in which the stroke was defined as haemorrhagic and possibly also included a small proportion of subarachnoid haemorrhages.263339 An estimate that excluded these studies was also performed. Those strokes grouped as subarachnoid haemorrhages in the analysis included all the pathological types-that is, aneurysmal, arteriovenous malformation, or primary (origin unknown). In all studies confounding by age was dealt with by age adjustment, matching, or restriction of the age group studied. As cigarette consumption is only weakly linked to age it seems unlikely that any residual confounding by age could have produced the observed association.
Blood pressure and possibly obesity are risk factors for stroke and also may be influenced by smoking. Most evidence suggests that cigarette smokers are thinner and have lower blood pressures than nonsmokers. Almost certainly smoking causes these changes in blood pressure and weight. This suggests that adjustment for blood pressure or weight may overestimate the risks from cigarette smoking. This increase in the relative risk was seen in all the eight relative risk results from four studies (table IV) . When pooled the relative risks adjusted for age and blood pressure or obesity, or both, were substantially higher than those adjusted for age alone. Pooled total (95% 1-9 (1 6 2-6 (2-3 confidence interval) to 2-1) to [2] [3] [4] [5] [6] [7] [8] [9] Alcohol consumption has been linked to stroke in some but not all investigations."4 Excessive alcohol consumption is associated with cigarette smoking.5" Table V presents those studies that measured alcohol consumption and adjusted for it in the analysis. The association of stroke with cigarette smoking seemed to remain after adjustment for alcohol consumption; indeed, adjustment in these studies tended not to reduce the relative risk, which suggests that alcohol consumption is not an important confounding variable. Furthermore, the excess risk in women compared with men argues strongly against the possibility that the relation between stroke and cigarette smoking is the result of the confounding effect of alcohol. [2] [3] [4] (1 9 to 2-9)
ASSESSMENT OF POSSIBLE PUBLICATION BIAS
We assessed the possibility that the selective publication of studies indicating a positive association might produce a misleading picture. Figure 1 plots the relative risk against the number of strokes on which the relative risk was based. Publication bias would be suspected if there was a deficit of estimates in small studies which were around or below 10. We would expect the larger studies to lie closer to the marked "true" value shown by the vertical broken line. Although the spread of points was not entirely even the pattern still suggested that there was an association between cigarette smoking and stroke. The most likely explanation for this uneven pattern is that larger studies tend to include many older patients, who seem to have a lower relative risk. Figure 2 , which plots only strokes in patients aged under 55, is more evenly distributed and would support this explanation.
As large studies are almost always published the scope for publication bias among them is reduced. The relative risk for studies with more than 500 cases was 1 3, with more than 100 cases 1-5, and with more than 50 cases 1-5.
Discussion
The results of this meta-analysis provide strong evidence of the excess risk of stroke among cigarette smokers. Stroke should, therefore, be firmly added to the list of diseases related to smoking. The overall excess relative risk of 50% is modest by epidemiological standards but reflects a large potential for preventing stroke. Neither publication bias nor the confounding effects of age, obesity, blood pressure, or alcohol seemed to account for the findings. The dose response noted adds further weight to the case against cigarettes. In view of the increased risk among ex-smokers smoking probably causes strokes principally through structural damage to the arterial walls of an atheromatous nature. Structural damage of an aneurysmal form may well be responsible for causing subarachnoid haemorrhages.
The meta-analysis allowed examination of the variation in the risks of cigarette smoking by subtype of stroke, sex, age, and number of cigarettes smoked. Not unexpectedly, large differences in the risk were found with some variables. Subarachnoid haemorrhage was considerably more common among smokers than nonsmokers-. all studies showed an excess risk -but other strokes also seemed to be related to smoking. The increased risk of cerebral infarction was not surprising in view of the well established dangers of cigarette smoking for other atherosclerotic disorders -namely, heart attacks and peripheral vascular disease. This study did not, however, confirm smoking as a cause of cerebral haemorrhage, but any adverse or beneficial effect of cigarettes for this condition is small. Considerably more data and better diagnosis with computed tomography will be required for the picture to become clearer.
A small difference was seen between the sexes with a greater risk for women. A recent analysis of the Medical Research Council's trial on mild hypertension suggested significantly greater risks of cardiovascular disease related to stroke in women.56 These are fairly new findings and have implications for health promotion strategies. Reasons for the differences are speculative and may include a higher dose per unit of body mass from a single cigarette in women, the concurrent use of oral contraceptives, and even a small protective effect of the widespread use of alcohol in men who smoke.
One of the most striking findings from this metaanalysis was the changing relative risk with age. The risks of stroke associated with smoking are apparently present in all age groups but are far greater in younger people. In those publications that provided data stratified by age the trend was for a decreasing relative risk with age. This finding may explain the inconsistencies seen among studies. Coronary heart disease seems to have a similar pattern of falling relative risk for smoking with age.'7 The explanation for this effect is not clear but may be that similar differences in risk produce more distinct relative risk values in the young when the disease is rare. An additional contributory factor may be less accurate diagnosis in older patients, producing an apparent dilution of any true effect. Old smokers may also be more cautious or lighter smokers with consequently reduced risks.
The increased risks of stroke of ex-smokers, when noted, have usually been considered unlikely. 46 The meta-analysis suggests that ex-smokers have around a 50% increased risk of suffering a stroke before the age of 75. The possibility that some people who reported themselves as ex-smokers were in reality current smokers cannot be dismissed. The diminishing relative risk with age was again apparent in ex-cigarette smokers.
Examination of adjusting for obesity or blood pressure, or both, on the relative risk of stroke associated with cigarette smoking produced a distinct effect: the adjustment seemed to increase the relative risk. As cigarette smoking seems to lower weight and blood pressure the adjustment might seem unreasonably to overestimate the effect of smoking. Possibly in the Framingham study the value adjusted for blood pressure was presented because it was significantly higher, whereas the value adjusted for age, though higher, failed to reach the required p value of 0-05.4
All the above conclusions depend on an acceptance of the validity of meta-analysis. The principal criticism is that studies and populations that are clearly different are being grouped together on the assumption that they are similar. Even within many individual studies, however, groups that are likely to differ substantially have been combined so the same problems apply to both individual studies and combined results. An advantage of meta-analysis is that it allows examination of subgroups when individual studies have inadequate numbers. While different studies have used different methods-for example, questionnaires-it seems unlikely that differences in detecting cigarette smokers would have introduced any serious errors or altered the conclusions.
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